img

Global Diagnostic Nuclear Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Diagnostic Nuclear Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Nuclear Drugs are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis
Diagnostic Nuclear Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Diagnostic Nuclear Drug market is projected to reach US$ 7534.8 million in 2029, increasing from US$ 4722 million in 2022, with the CAGR of 6.9% during the period of 2024 to 2029. Demand from Oncology and Cardiology are the major drivers for the industry.
The diagnostic radioisotopes market is driven by the increasing prevalence of cancer and cardiovascular diseases, which require advanced imaging techniques for accurate diagnosis and treatment planning. Diagnostic radioisotopes are radioactive compounds used in nuclear medicine imaging to visualize and evaluate physiological processes and detect specific diseases in the body. The rise in the aging population and the need for early and precise diagnosis contribute to market growth. Moreover, advancements in radiopharmaceutical research and the development of new radioisotopes have improved the sensitivity and specificity of diagnostic imaging. However, the market also faces challenges, including the high cost of production and limited availability of some radioisotopes. Additionally, ensuring regulatory compliance and addressing concerns regarding radiation safety can pose obstacles for manufacturers and healthcare facilities. To succeed, companies must focus on research and development to offer innovative and diverse diagnostic radioisotopes, collaborate with healthcare providers to improve nuclear medicine imaging capabilities, and address the challenges to meet the increasing demand for effective and safe diagnostic imaging solutions.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Diagnostic Nuclear Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
Novartis
SIEMENS
China Isotope & Radiation
Dongcheng
Lantheus
Eli Lilly
Segment by Type
Tc-99m
F-18
Other

Segment by Application


Oncology
Cardiology
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Diagnostic Nuclear Drug market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Diagnostic Nuclear Drug introduction, etc. Diagnostic Nuclear Drug Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Diagnostic Nuclear Drug market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Diagnostic Nuclear Drug
1.1 Diagnostic Nuclear Drug Market Overview
1.1.1 Diagnostic Nuclear Drug Product Scope
1.1.2 Diagnostic Nuclear Drug Market Status and Outlook
1.2 Global Diagnostic Nuclear Drug Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Diagnostic Nuclear Drug Market Size by Region (2018-2029)
1.4 Global Diagnostic Nuclear Drug Historic Market Size by Region (2018-2024)
1.5 Global Diagnostic Nuclear Drug Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Diagnostic Nuclear Drug Market Size (2018-2029)
1.6.1 North America Diagnostic Nuclear Drug Market Size (2018-2029)
1.6.2 Europe Diagnostic Nuclear Drug Market Size (2018-2029)
1.6.3 Asia-Pacific Diagnostic Nuclear Drug Market Size (2018-2029)
1.6.4 Latin America Diagnostic Nuclear Drug Market Size (2018-2029)
1.6.5 Middle East & Africa Diagnostic Nuclear Drug Market Size (2018-2029)
2 Diagnostic Nuclear Drug Market by Type
2.1 Introduction
2.1.1 Tc-99m
2.1.2 F-18
2.1.3 Other
2.2 Global Diagnostic Nuclear Drug Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Diagnostic Nuclear Drug Historic Market Size by Type (2018-2024)
2.2.2 Global Diagnostic Nuclear Drug Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Diagnostic Nuclear Drug Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Diagnostic Nuclear Drug Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Diagnostic Nuclear Drug Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Diagnostic Nuclear Drug Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Diagnostic Nuclear Drug Revenue Breakdown by Type (2018-2029)
3 Diagnostic Nuclear Drug Market Overview by Application
3.1 Introduction
3.1.1 Oncology
3.1.2 Cardiology
3.1.3 Other
3.2 Global Diagnostic Nuclear Drug Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Diagnostic Nuclear Drug Historic Market Size by Application (2018-2024)
3.2.2 Global Diagnostic Nuclear Drug Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Diagnostic Nuclear Drug Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Diagnostic Nuclear Drug Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Diagnostic Nuclear Drug Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Diagnostic Nuclear Drug Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Diagnostic Nuclear Drug Revenue Breakdown by Application (2018-2029)
4 Diagnostic Nuclear Drug Competition Analysis by Players
4.1 Global Diagnostic Nuclear Drug Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diagnostic Nuclear Drug as of 2022)
4.3 Date of Key Players Enter into Diagnostic Nuclear Drug Market
4.4 Global Top Players Diagnostic Nuclear Drug Headquarters and Area Served
4.5 Key Players Diagnostic Nuclear Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Diagnostic Nuclear Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Cardinal Health
5.1.1 Cardinal Health Profile
5.1.2 Cardinal Health Main Business
5.1.3 Cardinal Health Diagnostic Nuclear Drug Products, Services and Solutions
5.1.4 Cardinal Health Diagnostic Nuclear Drug Revenue (US$ Million) & (2018-2024)
5.1.5 Cardinal Health Recent Developments
5.2 GE Healthcare
5.2.1 GE Healthcare Profile
5.2.2 GE Healthcare Main Business
5.2.3 GE Healthcare Diagnostic Nuclear Drug Products, Services and Solutions
5.2.4 GE Healthcare Diagnostic Nuclear Drug Revenue (US$ Million) & (2018-2024)
5.2.5 GE Healthcare Recent Developments
5.3 Curium Pharma
5.3.1 Curium Pharma Profile
5.3.2 Curium Pharma Main Business
5.3.3 Curium Pharma Diagnostic Nuclear Drug Products, Services and Solutions
5.3.4 Curium Pharma Diagnostic Nuclear Drug Revenue (US$ Million) & (2018-2024)
5.3.5 Jubilant Pharma Recent Developments
5.4 Jubilant Pharma
5.4.1 Jubilant Pharma Profile
5.4.2 Jubilant Pharma Main Business
5.4.3 Jubilant Pharma Diagnostic Nuclear Drug Products, Services and Solutions
5.4.4 Jubilant Pharma Diagnostic Nuclear Drug Revenue (US$ Million) & (2018-2024)
5.4.5 Jubilant Pharma Recent Developments
5.5 Bracco Imaging
5.5.1 Bracco Imaging Profile
5.5.2 Bracco Imaging Main Business
5.5.3 Bracco Imaging Diagnostic Nuclear Drug Products, Services and Solutions
5.5.4 Bracco Imaging Diagnostic Nuclear Drug Revenue (US$ Million) & (2018-2024)
5.5.5 Bracco Imaging Recent Developments
5.6 Novartis
5.6.1 Novartis Profile
5.6.2 Novartis Main Business
5.6.3 Novartis Diagnostic Nuclear Drug Products, Services and Solutions
5.6.4 Novartis Diagnostic Nuclear Drug Revenue (US$ Million) & (2018-2024)
5.6.5 Novartis Recent Developments
5.7 SIEMENS
5.7.1 SIEMENS Profile
5.7.2 SIEMENS Main Business
5.7.3 SIEMENS Diagnostic Nuclear Drug Products, Services and Solutions
5.7.4 SIEMENS Diagnostic Nuclear Drug Revenue (US$ Million) & (2018-2024)
5.7.5 SIEMENS Recent Developments
5.8 China Isotope & Radiation
5.8.1 China Isotope & Radiation Profile
5.8.2 China Isotope & Radiation Main Business
5.8.3 China Isotope & Radiation Diagnostic Nuclear Drug Products, Services and Solutions
5.8.4 China Isotope & Radiation Diagnostic Nuclear Drug Revenue (US$ Million) & (2018-2024)
5.8.5 China Isotope & Radiation Recent Developments
5.9 Dongcheng
5.9.1 Dongcheng Profile
5.9.2 Dongcheng Main Business
5.9.3 Dongcheng Diagnostic Nuclear Drug Products, Services and Solutions
5.9.4 Dongcheng Diagnostic Nuclear Drug Revenue (US$ Million) & (2018-2024)
5.9.5 Dongcheng Recent Developments
5.10 Lantheus
5.10.1 Lantheus Profile
5.10.2 Lantheus Main Business
5.10.3 Lantheus Diagnostic Nuclear Drug Products, Services and Solutions
5.10.4 Lantheus Diagnostic Nuclear Drug Revenue (US$ Million) & (2018-2024)
5.10.5 Lantheus Recent Developments
5.11 Eli Lilly
5.11.1 Eli Lilly Profile
5.11.2 Eli Lilly Main Business
5.11.3 Eli Lilly Diagnostic Nuclear Drug Products, Services and Solutions
5.11.4 Eli Lilly Diagnostic Nuclear Drug Revenue (US$ Million) & (2018-2024)
5.11.5 Eli Lilly Recent Developments
6 North America
6.1 North America Diagnostic Nuclear Drug Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Diagnostic Nuclear Drug Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Diagnostic Nuclear Drug Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Diagnostic Nuclear Drug Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Diagnostic Nuclear Drug Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Diagnostic Nuclear Drug Market Dynamics
11.1 Diagnostic Nuclear Drug Industry Trends
11.2 Diagnostic Nuclear Drug Market Drivers
11.3 Diagnostic Nuclear Drug Market Challenges
11.4 Diagnostic Nuclear Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Diagnostic Nuclear Drug Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Diagnostic Nuclear Drug Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Diagnostic Nuclear Drug Market Size Share by Region (2018-2024)
Table 4. Global Diagnostic Nuclear Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Diagnostic Nuclear Drug Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Diagnostic Nuclear Drug Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Diagnostic Nuclear Drug Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Diagnostic Nuclear Drug Revenue Market Share by Type (2018-2024)
Table 9. Global Diagnostic Nuclear Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Diagnostic Nuclear Drug Revenue Market Share by Type (2024-2029)
Table 11. North America Diagnostic Nuclear Drug Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Diagnostic Nuclear Drug Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Diagnostic Nuclear Drug Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Diagnostic Nuclear Drug Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Diagnostic Nuclear Drug Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Diagnostic Nuclear Drug Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Diagnostic Nuclear Drug Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Diagnostic Nuclear Drug Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Diagnostic Nuclear Drug Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Diagnostic Nuclear Drug Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Diagnostic Nuclear Drug Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Diagnostic Nuclear Drug Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Diagnostic Nuclear Drug Revenue Market Share by Application (2018-2024)
Table 24. Global Diagnostic Nuclear Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Diagnostic Nuclear Drug Revenue Market Share by Application (2024-2029)
Table 26. North America Diagnostic Nuclear Drug Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Diagnostic Nuclear Drug Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Diagnostic Nuclear Drug Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Diagnostic Nuclear Drug Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Diagnostic Nuclear Drug Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Diagnostic Nuclear Drug Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Diagnostic Nuclear Drug Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Diagnostic Nuclear Drug Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Diagnostic Nuclear Drug Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Diagnostic Nuclear Drug Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Diagnostic Nuclear Drug Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Diagnostic Nuclear Drug Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diagnostic Nuclear Drug as of 2022)
Table 39. Date of Key Players Enter into Diagnostic Nuclear Drug Market
Table 40. Global Diagnostic Nuclear Drug Key Players Headquarters and Area Served
Table 41. Diagnostic Nuclear Drug Product Solution and Service
Table 42. Global Diagnostic Nuclear Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Cardinal Health Basic Information List
Table 45. Cardinal Health Description and Business Overview
Table 46. Cardinal Health Diagnostic Nuclear Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Diagnostic Nuclear Drug Business of Cardinal Health (2018-2024)
Table 48. Cardinal Health Recent Developments
Table 49. GE Healthcare Basic Information List
Table 50. GE Healthcare Description and Business Overview
Table 51. GE Healthcare Diagnostic Nuclear Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Diagnostic Nuclear Drug Business of GE Healthcare (2018-2024)
Table 53. GE Healthcare Recent Developments
Table 54. Curium Pharma Basic Information List
Table 55. Curium Pharma Description and Business Overview
Table 56. Curium Pharma Diagnostic Nuclear Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in Diagnostic Nuclear Drug Business of Curium Pharma (2018-2024)
Table 58. Curium Pharma Recent Developments
Table 59. Jubilant Pharma Basic Information List
Table 60. Jubilant Pharma Description and Business Overview
Table 61. Jubilant Pharma Diagnostic Nuclear Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in Diagnostic Nuclear Drug Business of Jubilant Pharma (2018-2024)
Table 63. Jubilant Pharma Recent Developments
Table 64. Bracco Imaging Basic Information List
Table 65. Bracco Imaging Description and Business Overview
Table 66. Bracco Imaging Diagnostic Nuclear Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in Diagnostic Nuclear Drug Business of Bracco Imaging (2018-2024)
Table 68. Bracco Imaging Recent Developments
Table 69. Novartis Basic Information List
Table 70. Novartis Description and Business Overview
Table 71. Novartis Diagnostic Nuclear Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in Diagnostic Nuclear Drug Business of Novartis (2018-2024)
Table 73. Novartis Recent Developments
Table 74. SIEMENS Basic Information List
Table 75. SIEMENS Description and Business Overview
Table 76. SIEMENS Diagnostic Nuclear Drug Products, Services and Solutions
Table 77. Revenue (US$ Million) in Diagnostic Nuclear Drug Business of SIEMENS (2018-2024)
Table 78. SIEMENS Recent Developments
Table 79. China Isotope & Radiation Basic Information List
Table 80. China Isotope & Radiation Description and Business Overview
Table 81. China Isotope & Radiation Diagnostic Nuclear Drug Products, Services and Solutions
Table 82. Revenue (US$ Million) in Diagnostic Nuclear Drug Business of China Isotope & Radiation (2018-2024)
Table 83. China Isotope & Radiation Recent Developments
Table 84. Dongcheng Basic Information List
Table 85. Dongcheng Description and Business Overview
Table 86. Dongcheng Diagnostic Nuclear Drug Products, Services and Solutions
Table 87. Revenue (US$ Million) in Diagnostic Nuclear Drug Business of Dongcheng (2018-2024)
Table 88. Dongcheng Recent Developments
Table 89. Lantheus Basic Information List
Table 90. Lantheus Description and Business Overview
Table 91. Lantheus Diagnostic Nuclear Drug Products, Services and Solutions
Table 92. Revenue (US$ Million) in Diagnostic Nuclear Drug Business of Lantheus (2018-2024)
Table 93. Lantheus Recent Developments
Table 94. Eli Lilly Basic Information List
Table 95. Eli Lilly Description and Business Overview
Table 96. Eli Lilly Diagnostic Nuclear Drug Products, Services and Solutions
Table 97. Revenue (US$ Million) in Diagnostic Nuclear Drug Business of Eli Lilly (2018-2024)
Table 98. Eli Lilly Recent Developments
Table 99. North America Diagnostic Nuclear Drug Market Size by Country (2018-2024) & (US$ Million)
Table 100. North America Diagnostic Nuclear Drug Market Size by Country (2024-2029) & (US$ Million)
Table 101. Europe Diagnostic Nuclear Drug Market Size by Country (2018-2024) & (US$ Million)
Table 102. Europe Diagnostic Nuclear Drug Market Size by Country (2024-2029) & (US$ Million)
Table 103. Asia-Pacific Diagnostic Nuclear Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 104. Asia-Pacific Diagnostic Nuclear Drug Market Size by Region (2018-2024) & (US$ Million)
Table 105. Asia-Pacific Diagnostic Nuclear Drug Market Size by Region (2024-2029) & (US$ Million)
Table 106. Asia-Pacific Diagnostic Nuclear Drug Market Share by Region (2018-2024)
Table 107. Asia-Pacific Diagnostic Nuclear Drug Market Share by Region (2024-2029)
Table 108. Latin America Diagnostic Nuclear Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 109. Latin America Diagnostic Nuclear Drug Market Size by Country (2018-2024) & (US$ Million)
Table 110. Latin America Diagnostic Nuclear Drug Market Size by Country (2024-2029) & (US$ Million)
Table 111. Middle East & Africa Diagnostic Nuclear Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 112. Middle East & Africa Diagnostic Nuclear Drug Market Size by Country (2018-2024) & (US$ Million)
Table 113. Middle East & Africa Diagnostic Nuclear Drug Market Size by Country (2024-2029) & (US$ Million)
Table 114. Diagnostic Nuclear Drug Market Trends
Table 115. Diagnostic Nuclear Drug Market Drivers
Table 116. Diagnostic Nuclear Drug Market Challenges
Table 117. Diagnostic Nuclear Drug Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diagnostic Nuclear Drug Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Diagnostic Nuclear Drug Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Diagnostic Nuclear Drug Market Share by Regions: 2022 VS 2029
Figure 4. Global Diagnostic Nuclear Drug Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Diagnostic Nuclear Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Diagnostic Nuclear Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Diagnostic Nuclear Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Diagnostic Nuclear Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Diagnostic Nuclear Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Tc-99m
Figure 11. Global Tc-99m Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of F-18
Figure 13. Global F-18 Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Other
Figure 15. Global Other Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Global Diagnostic Nuclear Drug Market Size Share by Type: 2022 & 2029
Figure 17. North America Diagnostic Nuclear Drug Revenue Market Share by Type (2018-2029)
Figure 18. Europe Diagnostic Nuclear Drug Revenue Market Share by Type (2018-2029)
Figure 19. Asia-Pacific Diagnostic Nuclear Drug Revenue Market Share by Type (2018-2029)
Figure 20. Latin America Diagnostic Nuclear Drug Revenue Market Share by Type (2018-2029)
Figure 21. Middle East and Africa Diagnostic Nuclear Drug Revenue Market Share by Type (2018-2029)
Figure 22. Oncology Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Cardiology Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 24. Other Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 25. Global Diagnostic Nuclear Drug Market Size Share by Application: 2022 & 2029
Figure 26. North America Diagnostic Nuclear Drug Revenue Market Share by Application (2018-2029)
Figure 27. Europe Diagnostic Nuclear Drug Revenue Market Share by Application (2018-2029)
Figure 28. Asia-Pacific Diagnostic Nuclear Drug Revenue Market Share by Application (2018-2029)
Figure 29. Latin America Diagnostic Nuclear Drug Revenue Market Share by Application (2018-2029)
Figure 30. Middle East and Africa Diagnostic Nuclear Drug Revenue Market Share by Application (2018-2029)
Figure 31. Diagnostic Nuclear Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 32. Global Top 5 and Top 10 Players Diagnostic Nuclear Drug Market Share in 2022
Figure 33. North America Diagnostic Nuclear Drug Market Share by Country (2018-2029)
Figure 34. United States Diagnostic Nuclear Drug Market Size (2018-2029) & (US$ Million)
Figure 35. Canada Diagnostic Nuclear Drug Market Size (2018-2029) & (US$ Million)
Figure 36. Germany Diagnostic Nuclear Drug Market Size (2018-2029) & (US$ Million)
Figure 37. France Diagnostic Nuclear Drug Market Size (2018-2029) & (US$ Million)
Figure 38. U.K. Diagnostic Nuclear Drug Market Size (2018-2029) & (US$ Million)
Figure 39. Italy Diagnostic Nuclear Drug Market Size (2018-2029) & (US$ Million)
Figure 40. Russia Diagnostic Nuclear Drug Market Size (2018-2029) & (US$ Million)
Figure 41. Nordic Countries Diagnostic Nuclear Drug Market Size (2018-2029) & (US$ Million)
Figure 42. Asia-Pacific Diagnostic Nuclear Drug Market Share by Region (2018-2029)
Figure 43. China Diagnostic Nuclear Drug Market Size (2018-2029) & (US$ Million)
Figure 44. Japan Diagnostic Nuclear Drug Market Size (2018-2029) & (US$ Million)
Figure 45. South Korea Diagnostic Nuclear Drug Market Size (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Diagnostic Nuclear Drug Market Size (2018-2029) & (US$ Million)
Figure 47. India Diagnostic Nuclear Drug Market Size (2018-2029) & (US$ Million)
Figure 48. Australia Diagnostic Nuclear Drug Market Size (2018-2029) & (US$ Million)
Figure 49. Latin America Diagnostic Nuclear Drug Market Share by Country (2018-2029)
Figure 50. Mexico Diagnostic Nuclear Drug Market Size (2018-2029) & (US$ Million)
Figure 51. Brazil Diagnostic Nuclear Drug Market Size (2018-2029) & (US$ Million)
Figure 52. Middle East & Africa Diagnostic Nuclear Drug Market Share by Country (2018-2029)
Figure 53. Turkey Diagnostic Nuclear Drug Market Size (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Diagnostic Nuclear Drug Market Size (2018-2029) & (US$ Million)
Figure 55. UAE Diagnostic Nuclear Drug Market Size (2018-2029) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report